ProPhase Labs Inc. (PRPH)
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
Im Cannabis Corp (IMCC)
IM Cannabis Reports Second Quarter 2025 Financial Results
Monopar Therapeutics Inc. (MNPR)
Monopar Therapeutics ReportsSecond Quarter 2025 Financial Results and Recent Developments
180 Life Sciences Corp. (ATNFW)
180 Life Sciences (ETHZilla) Holds 82,186 ETH
Elicio Therapeutics Inc (ELTX)
Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients
Integer Holdings Corp (ITGR)
Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4
Aprea Therapeutics Inc. (APRE)
Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
PolyPid (PYPD)
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
Core Molding Technologies Inc (CMT)
Core Molding Technologies to Present and Host 1x1 Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26, 2025
electroCore Inc. (ECOR)
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
Mereo BioPharma (MREO)
BioXcel Therapeutics Inc. (BTAI)
BioXcel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Updates